Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. Rise leverages its target discovery expertise to understand microbiome gut biology as it relates to regulation of immune function. In turn, we then utilize these microbiome discoveries to identify new immune regulatory pathways and develop unique, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity and cancer.